⁯⁯⁯⁯⁯
=====

As already previously reported the EXCLI Journal closely cooperates with the Archives of Toxicology as a partner for articles focussing on basic and clinical research (Bolt, 2011\[[@R7]\]; Bolt and Stewart, 2011\[[@R9]\]). To give our readers an overview over current cutting-edge topics in toxicology we publish a compilation of brief 'key messages' from the most cited articles (Table 1[(Tab. 1)](#T1){ref-type="fig"}). (References in Table 1: Bolt et al., 2012\[[@R8]\]; Kell, 2010\[[@R30]\]; Pestka, 2010\[[@R45]\]; Adler et al., 2011\[[@R1]\]; Xie et al., 2010\[[@R68]\]; Drobná et al., 2010\[[@R14]\]; Valdiglesias et al., 2010\[[@R62]\]; Foldbjerg et al., 2011\[[@R19]\]; Mamas et al., 2011\[[@R38]\]; Brozmanová et al., 2010\[[@R11]\]; Elcombe et al., 2010\[[@R18]\]; Nielsen and Wolkoff, 2010\[[@R41]\]; Rand et al., 2010\[[@R47]\]; Nogueira and Rocha, 2011\[[@R43]\]; Baird and Dinkova-Kostava, 2011\[[@R4]\]; Slocum and Kensler, 2011\[[@R58]\]; Druwe and Vaillancourt, 2010\[[@R15]\]; Prigol et al., 2010\[[@R46]\]; Sriram et al., 2010\[[@R59]\]; van Berlo et al., 2010\[[@R63]\]; Read et al., 2010\[[@R48]\]; Kirsch-Volders et al., 2011\[[@R32]\]; Wobus and Löser, 2011\[[@R67]\]; Bakhiya and Appel, 2010\[[@R5]\]; Kawai et al., 2010\[[@R29]\]; Marano et al., 2011\[[@R39]\]; Wagner et al., 2010\[[@R64]\]; Al-Rawi et al., 2011\[[@R2]\]; Lehmann et al., 2010\[[@R34]\]; Wang et al., 2010\[[@R65]\]; Hoshino et al., 2011\[[@R26]\]; Rodrigues et al., 2010\[[@R50]\]; Liu et al., 2010\[[@R37]\]; Audebert et al., 2011\[[@R3]\]; Wang et al., 2011\[[@R66]\]; Barcelos et al., 2011\[[@R6]\]; Clift et al., 2011\[[@R13]\]; Kim et al., 2011\[[@R31]\]; Yen et al., 2011\[[@R69]\]; Yun et al., 2010\[[@R71]\]; Sinicropi et al., 2010\[[@R57]\]; Bosetti et al., 2010\[[@R10]\]; Repetto et al., 2010\[[@R49]\]; Nishimura et al., 2010\[[@R42]\]; Jeong et al., 2010\[[@R27]\]; Calabrese, 2011\[[@R12]\]; Heng et al., 2011\[[@R24]\]; Park et al., 2011\[[@R44]\]; Shimamoto et al., 2011\[[@R56]\]; Rossato et al., 2011\[[@R53]\]; Gehrke et al., 2011\[[@R20]\]; Gibson et al., 2011\[[@R21]\]; Golka et al., 2011\[[@R22]\]; Durner et al., 2011\[[@R16]\]; Tripathi et al., 2010\[[@R60]\]; Haarmann-Stemmann et al., 2010\[[@R23]\]; Höfer et al., 2010\[[@R25]\]; Romano et al., 2010\[[@R51]\]; Shimada et al., 2010\[[@R55]\]; Liu et al., 2010\[[@R36]\]; Karp and Caspi, 2011\[[@R28]\]; Zhao et al., 2011\[[@R72]\]; Leppänen et al., 2011\[[@R35]\]; Truong et al., 2011\[[@R61]\]; Heng et al., 2011\[[@R24]\]; Mielke et al., 2011\[[@R40]\]; Yu et al., 2011\[[@R70]\]; Serpeloni et al., 2010\[[@R54]\]; Romero et al., 2010\[[@R52]\]; Klaric et al., 2010\[[@R33]\]; El-Agamy, 2010\[[@R17]\]) The citation ranking illustrates that research on nanoparticles has evolved to the currently most studied field in toxicology (Xie et al., 2010\[[@R68]\]; Foldbjerg et al., 2011\[[@R19]\]). As in the previous years oxidative stress research remains a cutting-edge topic (Kell, 2010\[[@R30]\]). Clearly, alternative methods of toxicity testing represent an emerging field of research. This development was further intensified by the 7^th^ amendment to the EU Cosmetics Directive that prohibits to put animal-tested cosmetics on the market after 2013 (Adler et al., 2011\[[@R1]\]). Although this directive has been controversely discussed it has nevertheless initiated intensive research activities to establish novel in vitro tests. The review of Adler and colleagues (2011\[[@R1]\]) gives a comprehensive analysis of the current status of alternative methods and of the time necessary to achieve full replacement of animal testing.
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